Alien Technology Transfer

Great tech ≠ guaranteed #NSF SBIR/STTR win. NSF backs companies, not just research. Without strong commercialization (value prop, customers, market validation, path to market), even great science can fall short. 👉Read the blog: alientt.com/the-role-of-a-… #Alien #STTR

#EICSTEPScaleUp supports companies ready to scale strategic innovations in Europe across Digital & Deep Tech, Clean Tech, and Biotech. Open to startups, SMEs, small mid-caps, and investors. 💶 Investments: €10M–€30M 📅 2026 cut-offs: Feb 11 | May 6 | Sept 9 | Nov 25 @EUeic

The SBIR/STTR lapse is creating uncertainty for U.S. innovators. A quick reauthorization is essential, with discussions focusing on permanent authorization, higher budgets, and stronger commercialization support. 📖 Full analysis: alientt.com/reauthorizatio… #SBIR #STTR #Alien

💡 The EIC Work Programme 2026 is out! 📖 Explore our breakdown of the key changes: alientt.com/key-changes-in… Read the full programme here: eic.ec.europa.eu/document/downl… #EICWorkProgramme2026 #EIC

From concept to commercialization — our latest blog breaks down all 3 phases of SBIR/STTR funding and how to prepare for each. 📖 Read more: alientt.com/breaking-down-… #SBIR #STTR @sbirgov

#Myogenica has received the @NIH #STTR Phase II grant. This grant has been awarded for its Fast-Track project "Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD". #Alien is proud to have supported their funding success. alientt.com/client/myogeni…

Day 24 of the U.S. Federal Shutdown: The Oct 1, 2025 shutdown & SBIR/STTR lapse delay federal funding for US startups ✅ Proposals can be submitted✅ Proposal reviews paused✅ Active projects continue with restrictions Read more: lnkd.in/du6NgWJN #governmentshutdown2025

#RespireRx Pharmaceuticals has been awarded the #NIH #SBIR Phase II grant for the development of a novel, preferring potentiator of the GABAA receptor for the treatment of epilepsy. #Alien is proud to have supported their funding success. Read more: alientt.com/client/respire…

@ViewMind_ has been awarded an @NIH #SBIR Phase I grant to evaluate its AI, VR, and eye-tracking solution for detecting beta-amyloid and tau linked to #Alzheimer’s disease. #Alien is proud to have supported their funding success. Read more - alientt.com/client/viewmin…

#ZveltTherapeutics has been awarded the #NIH STTR Phase II grant for developing a novel adipose targeted gene therapy for lipodystrophy. Learn more about this platform technology - alientt.com/client/zvelt-t… #Alien #NIH #STTR

NuSirt Sciences secured the #SBIR #NIH Phase II grant for the clinical validation of NS-0200, a drug to treat hypertension. @Alien_T_T is proud to have supported their funding success. Read more about their groundbreaking work: alientt.com/clients/nusirt… #Alien #NIH #Hypertension

💡#Grants vs. #Investors: Which is the smarter path for your startup? The most successful strategy isn't about choosing one over the other—it's about mastering how to use both. Read our latest blog to learn how to secure a stronger valuation - alientt.com/corporate/gran… #Alien

#Lactiga has been awarded a #STTR #NIH Phase I grant for its new #IBD therapeutic. The treatment uses secretory IgA (sIgA), a natural antibody from human milk that protects the gut from inflammation & helps maintain a healthy microbial balance. Learn more: alientt.com/clients/lactig…

#EndureBiotherapeutics has been awarded an #NIH @sbirgov Phase I grant for the development of Novel Engineered Native Bacteria to treat Familial Adenomatous Polyposis . To learn more about this platform technology, read here: alientt.com/clients/endure… @EndureBio #Alien

🚀SBIR/STTR funding can launch your innovation—but the process is tough. @Alien_T_T makes it easier. From strategy to submission, our PhD experts guide you at every step—boosting your chances of success. 💡Learn how: alientt.com/corporate/how-… #SBIR #STTR #Alien

@InnotechMed has been awarded an #NSF #SBIR Phase I grant to develop a saliva-based microfluidic test for early, multi-omics cancer diagnosis—starting with head and neck cancers. 👉Read more - alientt.com/clients/innote… #HealthTech #AlienTT

🚀Congrats to #CircularMaterials on qualifying for support via #EICAccelerator (March 2025 cut-off)! Pending due diligence, they’ll move toward equity funding. Their tech recovers 99.9% of critical raw materials from wastewater! 🌍💧 @EUeic #AlienTT #EUfunding

🚨@NIH is prioritizing human-relevant research over animal testing—with support from the FDA. Big moment for NAMs, organoids & AI tools. Startups & researchers: align now for SBIR/STTR funding. 📖Read more: alientt.com/corporate/nih-… #NIH #SBIR #STTR #GrantFunding #Alien

🌍 #EZMEMS joins top innovators at BIO International Convention 2025! From 16–19 June, they’ll present their biotech solutions at the EIC Pavilion—spotlighting European innovation on the global stage. 📍Catch them in Boston! #BIO2025 #EZMEMS #EIC

🎯 #NIH Funding Webinar — Back by Popular Demand! Got a life-changing health innovation? NIH SBIR/STTR grants offer $2M+ in funding—but the process can be overwhelming. Join us June 12 at 12 PM ET / 9 AM PT as Dr. Laetitia Gonzalez breaks it down! 🔗forms.gle/CfZtiPRZf7Zftw…